Daniel Humberto Pozza


AuthID: R-000-Q0T

Confirmed Publications: 49



11
TITLE: Treatment Sequencing Strategies in Lung Cancer
AUTHORS: Pozza, DH ; de Mello, RBA;
PUBLISHED: 2022, SOURCE: Chinese Journal of Lung Cancer, VOLUME: 25, ISSUE: 5
INDEXED IN: Scopus
12
13
TITLE: Lateral window technique: A focus review  Full Text
AUTHORS: Francisco Correia; Sónia Gouveia; Daniel H Pozza ; António Campos Felino; Ricardo Faria‐Almeida;
PUBLISHED: 2021, SOURCE: Oral Surgery
INDEXED IN: CrossRef: 1
IN MY: ORCID
14
TITLE: Manual lymphatic drainage and muscle energy techniques after third molar surgery: A randomized split-mouth clinical trial  Full Text
AUTHORS: Sérgio Pinheiro da Silva; Thiago Brasileiro de Vasconcelos; Itana Lisane Spinato; Daniel Humberto Pozza ; Miguel Meira e Cruz; Antônio Sérgio Guimarães;
PUBLISHED: 2021, SOURCE: Oral Surgery
INDEXED IN: Scopus CrossRef
IN MY: ORCID
15
TITLE: Pain as the fifth vital sign-A comparison between public and private healthcare systems  Full Text
AUTHORS: Pozza, DH ; Azevedo, LF ; Lopes, JMC ;
PUBLISHED: 2021, SOURCE: PLOS ONE, VOLUME: 16, ISSUE: 11
INDEXED IN: Scopus WOS CrossRef: 8
IN MY: ORCID
16
TITLE: Comparative cost-effectiveness analysis of avelumab plus axitinib versus pembrolizumab plus axitinib, ipilimumab plus nivolumab, and sunitnib for advanced renal cell carcinoma in the UK Perspective
AUTHORS: Ramon Andrade De Mello; Emili Ayoub; Pedro Castelo Branco; Victor Andre D De Almeida Zia; Andre Savio; Daniel Humberto Pozza ; Hakaru Tadokoro; Nelson Teich;
PUBLISHED: 2020, SOURCE: Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO) in JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 38, ISSUE: 6
INDEXED IN: WOS
17
TITLE: Current and future aspects of TIM-3 as biomarker or as potential targeted in non-small cell lung cancer scope: is there a role in clinical practice?
AUTHORS: De Mello, RA; Zhu, JH; Iavelberg, J; Potim, AH; Simonetti, D; Silva, JA; Castelo Branco, P; Pozza, DH ; Tajima, CC; Tolia, M; Antoniou, G;
PUBLISHED: 2020, SOURCE: TRANSLATIONAL LUNG CANCER RESEARCH, VOLUME: 9, ISSUE: 6
INDEXED IN: Scopus WOS CrossRef: 3
IN MY: ORCID
18
TITLE: MicroRNAs in Lung Cancer Oncogenesis and Tumor Suppression: How it Can Improve the Clinical Practice?
AUTHORS: Pozza, DH ; De Mello, RA; Araujo, RLC; Velcheti, V;
PUBLISHED: 2020, SOURCE: CURRENT GENOMICS, VOLUME: 21, ISSUE: 5
INDEXED IN: Scopus WOS CrossRef: 1
IN MY: ORCID
19
TITLE: Prevalence of morphological and structural changes in the stylohyoid chain
AUTHORS: Guimarães, ACA; Pozza, DH ; Guimarães, AS;
PUBLISHED: 2020, SOURCE: Journal of Clinical and Experimental Dentistry, VOLUME: 12, ISSUE: 11
INDEXED IN: Scopus CrossRef: 6
IN MY: ORCID
20
TITLE: The Role of MET Inhibitor Therapies in the Treatment of Advanced Non-Small Cell Lung Cancer
AUTHORS: Ramon Andrade De Mello; Nathalia Moises Neves; Giovanna Araujo Amaral; Estela Gudin Lippo; Pedro Castelo Branco; Daniel Humberto Pozza ; Carla Chizuru Tajima; Georgios Antoniou;
PUBLISHED: 2020, SOURCE: JOURNAL OF CLINICAL MEDICINE, VOLUME: 9, ISSUE: 6
INDEXED IN: WOS CrossRef: 12
IN MY: ORCID
Page 2 of 5. Total results: 49.

A place for researchers and their institutions

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service